Cardiac and inflammatory biomarker differences in adverse cardiac events after chimeric antigen receptor T-Cell therapy: an exploratory study.
Lee DH, Chandrasekhar S, Jain MD, Mhaskar R, Reid K, Lee SB, Corallo S, Hidalgo-Vargas MJ, Kumar A, Chavez J, Shah B, Lazaryan A, Khimani F, Nishihori T, Bachmeier C, Faramand R, Fradley MG, Jeong D, Oliveira GH, Locke FL, Davila ML, Alomar M.
Lee DH, et al. Among authors: fradley mg.
Cardiooncology. 2023 Apr 1;9(1):18. doi: 10.1186/s40959-023-00170-5.
Cardiooncology. 2023.
PMID: 37005652
Free PMC article.